Altogether, although γ-H2AX levels appeared to be higher in two-group comparisons of patients with as compared to patients without CEL, our findings do not seem to suggest that γ-H2AX levels may be a promising disease activity marker for CIS/early RRMS. The gene discussed is H2AX; the disease is Chronic Eosinophilic Leukemia, Not Otherwise Specified.